Clinical Trials for Galapagos

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Galapagos

Clinical Trials (8)

Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies

PHASE3Recruiting

546 participants

Started: Sep 9, 2024 · Completed: Jul 31, 2039

1 condition1 sponsor6 locations

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis

20 participants

Started: Aug 22, 2023 · Completed: Oct 31, 2025

5 conditions2 sponsors1 location

A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus

PHASE2Active, not recruiting

186 participants

Started: Jun 28, 2023 · Completed: Mar 31, 2026

1 condition1 sponsor84 locations

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

PHASE2Active, not recruiting

40 participants

Started: Feb 27, 2023 · Completed: Apr 30, 2026

1 condition1 sponsor54 locations

JAK Inhibition in Ulcerative Colitis

60 participants

Started: Dec 20, 2022 · Completed: Sep 30, 2026

1 condition2 sponsors1 location

Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis

PHASE4Not yet recruiting

40 participants

Started: Oct 31, 2022 · Completed: Oct 31, 2025

1 condition2 sponsors1 location

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

PHASE1/PHASE2Recruiting

274 participants

Started: Mar 9, 2022 · Completed: Jul 1, 2029

2 conditions1 sponsor10 locations

Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)

PHASE4Recruiting

100 participants

Started: May 12, 2021 · Completed: Sep 30, 2025

1 condition4 sponsors1 location